GGSK Read More GSK to Advance mRNA Influenza Vaccine Into Phase III DevelopmentSeptember 4, 2026 GSK plcĀ GSK announced that it plans to advance the mRNA-based seasonal influenza (flu) vaccine candidate into late-stage development.…